3Jiao X , Krasna MJ . Clinical significance of micrometastasis in lung and esophageal cancer:a new paradigm in thoracic oncology[J].Ann Thorac Surg,2002,74(1):278.
4Moll R.Cytokeratins as marks of differentiation[J].Progr Path-ol,1993,143(1):192.
5Pretlow TG,Schwartz S,Gaconia JM,et al.Prostate cancer and other xenografts from cells in peripheral blood of patients[J].Cancer Res,2000,60(15):4033.
6Iwao K,Watanabe T,Fujiwara Y,et al.Isolation of a novel human lung specific gene,LUNX,A potential molecular marker for detection of micrometastasis in Non-small cell lung cancer[J].Int J Cancer,2001,91(4):433.
7Salerno CT,Frezella S,Niehans GA,et al.Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptase polymerase chain reaction[J].Chest,1998,113(6):1526.
8Fukagawa T,Sasako M,Mann GB,et al.Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma[J].Cancer,2001,92(4):753.
9Dorudi S,Kinrade E,Marshall NC,et al.Genetic detection of lymph node micrometasteses in patients with colorectal cancer[J].Br J Surg,1998,85(1):98.
10Hirata H,Hisatomi H,Kawakita M,et al.Genetic detection for hematogenous micrometastesis in patients with various types of malignant tumors using Uroplakin Ⅱ derived primers in polymerase chain reaction[J].Oncol Rep,2003,10(4):963.
2Passlick B, Izbicki JR, Kubuschok B, et al. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognesis[J]. Ann Thorac Surg,1996,61(1) : 177-183.
3Wu J, Ohta Y, Minato H, et al. Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0cm or less in diameter [J]. Ann Thorac Surg,2001,71(6) : 1772-1778.
4Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer[J]. J Thorac Cardiovasc Surg,1978,76(6) : 832-839.
5Salerno CT, Frizelle S, Niehans GA, et sl. Detection of occult in non-small cell lung carcinoma by reverse transcriptase-polymerase chain reaction [ J ]. Chest, 1998,113(6) : 1526-1532.
6Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and secondary primary tumors in resected stage lung cancer[ J]. J Thorac Cardiovasc Surg,1995,169( 1 ) : 120-129.
7Dobashi K, Sugio K, Osaki T, et al. Micrometastatic p53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance. J Thorac Cardiovasc Surg , 1997,114: 339-346.
8Mountain CF. A new international staging system for lung cancer.Chest , 1986,89(4 Suppl) :225s-233s.
9Izbicki JR, Passliek B, Hooch SB,et al. Mode of spread in the early phase of lymphatic metastasis in non-smalbcell lung cancer: significance of nodal .1996,112 : 623-630.
10Krismann M, Todt B, Schroder J, et al. low specificity of cytok eratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Onco1,1995,13(11) : 2769-2775.
7Pfannschmidt J,Muley T,Bülzebruck H,et al.Prognostic assessment after surgical resection for non-small cell lung cancer:experiences in 2083 patients.Lung Cancer,2007,55:371 -377.
8Mountain CF.Revision in the international system for staging lung cancer.Chest,1997,111:1710-1717.
9Ichinose Y,Hara N,Ohta M,et al.Is T factor of TNM staging system a predominant prognostic factor in pathologic stage Ⅰ nonsmall cell lung cancer ? A multiviate prognostic factor analysis of 151 patients.J Thorac Cardiovasc Surg,1993,106:90-94.
